Edition:
United States

Resmed Inc (RMD.N)

RMD.N on New York Stock Exchange

101.64USD
14 Nov 2018
Change (% chg)

$-0.06 (-0.06%)
Prev Close
$101.70
Open
$102.75
Day's High
$102.82
Day's Low
$100.84
Volume
133,911
Avg. Vol
182,808
52-wk High
$116.61
52-wk Low
$82.86

Select another date:

Fri, Oct 5 2018

USITC to investigate Resmed for alleged patent infringement

WASHINGTON The U.S. International Trade Commission (USITC) said on Friday it would investigate California-based Resmed Inc for a patent infringement complaint related to sleep apnea mask systems.

USITC to investigate Resmed for alleged patent infringement

WASHINGTON, Oct 5 The U.S. International Trade Commission (USITC) said on Friday it would investigate California-based Resmed Inc for a patent infringement complaint related to sleep apnea mask systems.

NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.

UPDATE 1-NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Sept 11 Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.

NZ's Fisher & Paykel Healthcare files patent infringement complaint against ResMed

Sept 11 Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint in the United States against ResMed .

UPDATE 1-NZ's Fisher & Paykel cuts FY guidance on ResMed-linked legal costs

Sept 3 New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

NZ's Fisher & Paykel Healthcare cuts FY guidance on higher expected legal costs

Sept 3 New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

BRIEF-Infoscan Signs LoI With ResMed Polska

* REPORTED ON WEDNESDAY IT HAS SIGNED LETTER OF INTENT (LOI) WITH RESMED POLSKA ON COOPERATION

Select another date: